Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes : the TRIGR nested case-control ancillary study

Show full item record



Permalink

http://hdl.handle.net/10138/313670

Citation

TRIGR Investigators , Miettinen , M E , Niinistö , S , Erlund , I , Cuthbertson , D , Nucci , A M , Honkanen , J , Vaarala , O , Hyöty , H , Krischer , J P , Knip , M & Virtanen , S M 2020 , ' Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes : the TRIGR nested case-control ancillary study ' , Diabetologia , vol. 63 , no. 4 , pp. 780-787 . https://doi.org/10.1007/s00125-019-05077-4

Title: Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes : the TRIGR nested case-control ancillary study
Author: TRIGR Investigators; Miettinen, Maija E.; Niinistö, Sari; Erlund, Iris; Cuthbertson, David; Nucci, Anita M.; Honkanen, Jarno; Vaarala, Outi; Hyöty, Heikki; Krischer, Jeffrey P.; Knip, Mikael; Virtanen, Suvi M.
Contributor: University of Helsinki, Clinicum
University of Helsinki, HUS Children and Adolescents
University of Helsinki, HUS Children and Adolescents
Date: 2020-04
Language: eng
Number of pages: 8
Belongs to series: Diabetologia
ISSN: 0012-186X
URI: http://hdl.handle.net/10138/313670
Abstract: Aims/hypothesis Our aim was to study the association between serum 25-hydroxyvitamin D (25OHD) concentration and islet autoimmunity and type 1 diabetes in children with an increased genetic risk of type 1 diabetes. Methods Serum samples for 25OHD measurements were obtained in the Trial to Reduce IDDM in the Genetically at Risk (TRIGR) ancillary study (Divia) from children in 15 countries. Case children (n = 244) were defined as having positivity for at least two out of four diabetes-associated autoantibodies measured at any one sample. For each case child, two control children were selected matched for country and date of birth (+/- 1 year) (n = 488). Of the case children, 144 developed type 1 diabetes. Serum 25OHD was measured repeatedly in infancy and childhood and was compared according to age at the first seroconversion (at 6, 12 and 18 months prior to and at seroconversion) and calendar age (0, 6, 12 and 18 months). Results In children with islet autoimmunity, mean serum 25OHD concentration was lower 18 months prior to the age of first seroconversion of the case children compared with the control children (57.7 vs 64.8 nmol/l, p = 0.007). In children with type 1 diabetes (n = 144), mean serum 25OHD concentration was lower 18 months prior to the age of the first seroconversion (58.0 vs 65.0 nmol/l, p = 0.018) and at the calendar age of 12 months (70.1 vs 75.9 nmol/l, p = 0.031) than in their control counterparts. Analyses were adjusted for month of sample collection, human leucocyte antigen genotype, maternal type 1 diabetes and sex. Conclusions/interpretation The results suggest that early postnatal vitamin D may confer protection against the development of type 1 diabetes.
Subject: 25-Hydroxyvitamin D
Islet autoimmunity
Type 1 diabetes
Vitamin D
VITAMIN-D STATUS
HYDROLYZED INFANT FORMULA
PREGNANCY
3121 Internal medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Miettinen2020_A ... hydroxyvitaminDConcent.pdf 575.8Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record